A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
NCT06193187
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg
DRUG:
Entresto 50 mg
Sponsor
Dr. Reddy's Laboratories (Thailand) Limited